Efficacy evaluation of targeted therapy in patient with gastrointestinal stromal tumor

Cover Page

Cite item

Full Text

Abstract

An evaluation of efficacy of Gleevec in gastrointestinal stromal tumor is under discussion. Standard RECIST criteria underestimate the tumor response in contrast with highly sensitive PET evaluation. Proposed criteria modifications offer CT response evaluation. We demonstrated a difference between response criteria presenting a clinical case.

About the authors

A. A. Meshcheryakov

FGBU N.N. Blokhin Russian Cancer Research Center

Author for correspondence.
Email: a_meshcheryakov@mail.ru
Russian Federation

N. T. Tsymzhitova

FGBU N.N. Blokhin Russian Cancer Research Center

Russian Federation

D. A. Filonenko

FGBU N.N. Blokhin Russian Cancer Research Center

Russian Federation

B. M. Medvedeva

FGBU N.N. Blokhin Russian Cancer Research Center

Russian Federation

References

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2013 Meshcheryakov A.A., Tsymzhitova N.T., Filonenko D.A., Medvedeva B.M.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС77-66671 от  09.11.2009.